Adaptin Bio (APTN) Total Liabilities (2022 - 2026)

Adaptin Bio's Total Liabilities history runs 5 years deep, the most recent figure standing at $2.5 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 123.83% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (up 123.83% YoY), while the FY2025 annual figure was $2.1 million, down 51.41% from the prior year.
• Total Liabilities came in at $2.5 million for Q1 2026 at Adaptin Bio, up from $2.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $4.3 million in Q4 2024 to a low of $27804.0 in Q4 2022.
• A 5-year average of $999066.6 and a median of $220814.5 in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities surged 3730.9% in 2024 and slumped 51.41% in 2025, its largest moves.
• Adaptin Bio's Total Liabilities stood at $27804.0 in 2022, then surged by 307.41% to $113277.0 in 2023, then soared by 3730.9% to $4.3 million in 2024, then plunged by 51.41% to $2.1 million in 2025, then climbed by 17.7% to $2.5 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $2.5 million, $2.1 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison